STING1 and neoplasm: Activation of STING in macrophages resulted in enhanced type I IFN production, yielding decreased expression of M2-like markers (e.g., IL-10, Arg1) and increased expression of pro-inflammatory markers (e.g., IL-1β, TNF-α), consequently unleashing the anti-tumor properties of the macrophages (111).